Hermes Pharma
Private Company
Funding information not available
Overview
HERMES PHARMA is a specialized contract development and manufacturing organization (CDMO) focused exclusively on patient-centric, user-friendly oral dosage forms. Leveraging over 40 years of heritage through its sister company, it provides a full 'one-stop-shop' service across the pharmaceutical value chain, from R&D to logistics. Its core technology portfolio includes orally disintegrating granules, chewable tablets, effervescent tablets, instant drinks, and lozenges. The company targets pharmaceutical and nutraceutical clients seeking to differentiate their products and improve patient compliance.
Technology Platform
Portfolio of user-friendly oral dosage form technologies including orally disintegrating granules, chewable tablets, effervescent tablets, instant drinks, and lozenges, supported by specialized manufacturing and packaging solutions.
Opportunities
Risk Factors
Competitive Landscape
HERMES PHARMA competes in the fragmented CDMO market, facing competition from large multinational CMOs (e.g., Lonza, Catalent) and specialized European drug delivery firms. Its differentiation lies in its exclusive focus on user-friendly oral dosage forms and its integrated 'one-stop-shop' service model from development to commercial supply.